{"mainPropery":{"diseaseId":9315,"diseaseName":"Carcinoid tumor childhood","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9315/carcinoid-tumor-childhood","synonyms":[],"synonyms-with-source":[],"identifiers":[]},"diseaseCategories":[{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[{"resourceID":2732,"resourceName":"NET Patient Foundation","abbreviation":"UK and Ireland","address1":"Holly House (2nd Floor)","address2":"74 Upper Holly Walk","address3":"Leamington Spa","address4":"","address5":"","city":"Warwickshire","state":"","zip":"CV32 4JL","country":"United Kingdom","phone":"01926 883487 (General inquieries)","tty":"","tollFree":"0800 434 6476 (Helpline)","fax":"","email":"hello@netpatientfoundation.org","url":"https://www.netpatientfoundation.org/","freeText":""},{"resourceID":4284,"resourceName":"The Healing NET Foundation","abbreviation":"","address1":"200 Hill Avenue","address2":"Suite 4","address3":"","address4":"","address5":"","city":"Nashville","state":"TN","zip":"37210","country":"United States","phone":"615-3696463","tty":"","tollFree":"","fax":"","email":"info@thehealingnet.org","url":"https://www.thehealingnet.org/","freeText":""},{"resourceID":3888,"resourceName":"North American Neuroendocrine Tumor Society","abbreviation":"NANETS","address1":"136 Everett Road","address2":"","address3":"","address4":"","address5":"","city":"Albany","state":"NY","zip":"12205","country":"United States","phone":"(650) 762-6387","tty":"","tollFree":"","fax":"","email":"staff@nanets.net","url":"https://nanets.net/","freeText":""},{"resourceID":4289,"resourceName":"Neuroendocrine Cancer Awareness Network","abbreviation":"NCAN","address1":"3074 Brookchase Blvd","address2":"","address3":"","address4":"","address5":"","city":"Fort Mill","state":"SC","zip":"29707","country":"United States","phone":"866-850-9555","tty":"","tollFree":"","fax":"","email":"contact@netcancerawareness.org,help@netcancerawareness.org","url":"https://www.netcancerawareness.org/","freeText":"\r\n"}],"resource descriptions":[{"id":2538,"resourceId":329,"resourceName":"Neuroendocrine Tumor Research Foundation","descriptionText":"The&nbsp;<a href='https://netrf.org/funding-for-researchers/about/' target='_blank'>Neuroendocrine Tumor Research Foundation</a> is a non-profit organization to support neuroendocrine tumor (NET) research. Their mission is to accelerate scientific discovery that will help create new and more effective therapies for NETs. Each year they seek and fund basic, translational and clinical research proposals with the potential to further understanding of NETs and accelerate the development of diagnostic and therapeutic interventions for patients.","resourceClassificationName":"Research","resourceClassificationSectionName":"General Clinical Trials & Research"},{"id":2578,"resourceId":3888,"resourceName":"North American Neuroendocrine Tumor Society","descriptionText":"The&nbsp;<a href='https://nanets.net/net-guidelines-library' target='_blank'>North American Neuroendocrine Tumor Society</a> has published several consensus guidelines relating to the medical treatment and management of neuroendocrine tumors. Guidelines are developed pursuant to National Institute of Health (NIH) standards and serve as important references for practicing physicians.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"}],"overviewQuestion":{"questionId":0,"dateModified":"0001-01-01T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[{"productId":644,"genericName":"Gallium [Ga-68]","tradeName":"Netspot","tradeLink":"http://www.adacap.com/flash-news/2016/06/advanced-accelerator-applications-announces-fda-approval-of-netspottm-somakit-tate-a-kit-for-the-preparation-of-gallium-ga-68-dotatate-for-neuroendocrine-tumor-detection-2/","manufacturer":"","sponsor":"Advanced Accelerator Applications, USA","indication":"For use after radiolabeling with Ga 68, with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients.","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/name/netspot","medlinePlusLink":""}],"EncodedName":"Carcinoid_tumor_childhood"}